Comparison of immune activation parameters in immunologic or virologic progressor HICs, non-progressor HICs, ART-treated patients, chronic viremic patients and healthy donors.

Nicolas Noel (766081)
Nathalie Lerolle (766082)
Camille Lécuroux (130323)
Cécile Goujard (91698)
Alain Venet (130341)
Asier Saez-Cirion (352967)
Veronique Avettand-Fenoël (5664325)
Laurence Meyer (130347)
Faroudy Boufassa (252534)
Olivier Lambotte (252533)

Publication date

July 2015

DOI

10.1371/journal.pone.0131922.g002

Abstract

<p>(A) Proportion of activated circulating HLA-DR+CR38+ CD4+ T cells. (B) Proportion of activated circulating HLA-DR+CD38+ CD8+ T cells. (C) Plasma IP10 levels (pg/mL, logarithmic scale).</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Comparison of immune activation parameters in immunologic or virologic progressor HICs, non-progressor HICs, ART-treated patients, chronic viremic patients and healthy donors.

Nicolas Noel (766081)
Nathalie Lerolle (766082)
Camille Lécuroux (130323)
Cécile Goujard (91698)
Alain Venet (130341)
Asier Saez-Cirion (352967)
Veronique Avettand-Fenoël (5664325)
Laurence Meyer (130347)
Faroudy Boufassa (252534)
Olivier Lambotte (252533)

Open link

Publication date

July 2015

DOI

10.1371/journal.pone.0131922.g002

Abstract

<p>(A) Proportion of activated circulating HLA-DR+CR38+ CD4+ T cells. (B) Proportion of activated circulating HLA-DR+CD38+ CD8+ T cells. (C) Plasma IP10 levels (pg/mL, logarithmic scale).</p

Comparison of immune activation parameters in immunologic or virologic progressor HICs, non-progressor HICs, ART-treated patients, chronic viremic patients and healthy donors.

Abstract

Extracted data

Comparison of immune activation parameters in immunologic or virologic progressor HICs, non-progressor HICs, ART-treated patients, chronic viremic patients and healthy donors.

Abstract

Extracted data

Related items

Related items